In 1915, Arthur Felix and Edward Weil discovered that Proteus OX19 reacted to the same human immune antibodies as typhus. Other Proteus strains were similarly used to createreagents for other rickettsiae diseases, thus resulting in the commercial Weil-Felix antibody-agglutination test.